P21249 AF NFT

Major antigen

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeighcs5evdipmlnph43shfxquqf7efzzv5ikiv7p25d3irkwsagjoi/metadata.json
IPFS of structure file: 
bafybeicvhrtgnazput7hh7c2yg2nnhghsqozdlztg5kgcuwiyf6oau3id4/AF-P21249-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf49aEE1AA6fb3366CE362270cE160921093C19FD
First NFT owner address (bech32): 
genesis17jdwux4xlvekdn3kyfcvu9sfyyyncx0ats94p3
Current NFT ID #16950 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
16950
Accession (UniProt):
P21249
Name::
Major antigen
Experimental Method:
Predicted structure
Sequence source:
ONCHOCERCA VOLVULUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P21249 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P21249|ANT1_ONCVO Major antigen OS=Onchocerca volvulus OX=6282 GN=OVT1 PE=2 SV=2 MEKAREGAPSKERRSAEETISRETRHEIAGNDGDIGTDNIEYIDSMDSTGLGYGRTGEGISRILYEHPRDELINYKRRIDANTEQQREHADIMAALQRKIEEYRRRFAEIEGRLVVHDLNESGDLVNMKLKEEWLLSPKIKMEEISDVDFPNQLEDERRRAEDLAIQLQQERLQNDQLQSEIQRLRQQFGICIRDKERIYQTRERNFTRFLGEEQRKMMELWSELQRVRKQCAEYREQTERDLENQRNEFIKVIRHVSGIVRGLNIENGTHTLLSDLSSESGVEITQDTVLIEAVKRFHESQQQTAPVIGPELITELRLARAEDAGLHDELMRKYEESAKRIIELEARDDESHNKLVALESDLKRTRDRLAESQNALRKLYDMTYSYEINAEKETRSPSPTKGYVPPPEVVRSVRYVLNSRANDNNVLQRKLKNAEVQISELTTKNDSLEEIRRRLEKRIAEANRTITHRQRELDDAKHTVKDLEDRLKSLEQEKASIDSARHHLEDEIRKMREQFNSTLLDVERRAAEDADERIRKIDEETKIRISELTNRIEMLLEENKRLKDENDGMKNRIQDIEKEYNTIIRKLEEKDNALKNLENTRQRLVNELEEQRTRFDTMTSEFDNLRTNYDSANKNTVAIELTVKQIKEQRDEIIKQKDKLAKELADLENKLNNETKMRGDAEKLNQRHLDEIDNFKKQINEYITEVTIIRRQNDDFDTQMKTNQAKLSSMKNSLIAAKKEIEKLSEMNNRLQQDKNDLIGAKQKGDTELNLLTEKIRKVEIEFERIKKDNQELEDHERTARDDLKQETNRNHLLAKELEEARADIVALNDRLAKMDANFKIKLDETIKKSPADHETIKSRESKSEKIIVKHETKIYEINKYRAELEKLESDKDDLEKRIIGLQDELNEKDRDTDRLNAEIDDLKRKLQTEIEKVRKETTTVQERYHIEWDEERDNHQKKIDSMNALIDELRSKLNDAERAMADLQNRDSILERENNDWKEKSDALNMELDRLRDELLSVRRDAEKEINRYNTDLQTAARNEIKLLTPTNNEMKSQLNAAEDKINSLNKVITDQQNKIRDLTGEVHHLEGELKDAKGNVANLESELDTTRERIHLLGEQNASLQTELNKIKGDIDSLFGENDMLKTAKESNEAEIDRLKQKLQRSIENAKKYSDALDKLRPEYDRLQNLYREKIKQAENLTQAVQDLESRLNQSRRELRDATDKLIASEGDRNALRSEVEKLQHEVQFMREQLLRKTDEYQAALSDLVNAHRTAEDGRVNAVQALEARKYEINDLQSRLDNAEQYLVTLQQNYVAVENERDMLYDALRRLHSMIDRTVTINRFLIGVDESMDEKKETVLQTQKSPDGKSKERFDISDLDTNIQKLIGRIEKLELERNEYRDALDRIKKKSIESHIKINKQETIFTNIEDQLVDVEEEKRTLEMRLASAKQLLRSQEEALKQRDEERSHMKLKIAKFEMEARGKEAQLRQLNELVRNLRKDLETAQGDLGVLHDHEERWYAHKFHLESKLKDQESESQQIRLLVANFETERNSLNEKVRDLASRLQQTESKNADMKEDNDRLKKDLIKASTNEAELRRTIDQNSRVVSDNQILKDQLESAQNDLSNANNRKQQLENELLVVRSELRDLKQRFSDNANRIIDLQRHLTDAENDKKRLTNRLNSLEKTVSQQRTIETEIRQQLSLALNERNTLQNDLRDLQRRLARMETEKKIMNDKYDELEKIRASLIKRIELLDEEKRTMENILHETALQREAIESSLNALERENKELHRNCAQLQQQIAQLELENGNRLIQLTNKQREEYDKFAQNMRTEKIQIERIIENRERSLKSRINQLENQLNIMRDQLNSERRRRREISDKILSGEVNKLNVTLSGIPDAYEMYDRTLYTYNTYFGSPSFTVGSSSFDPNITDDSKIILKHSDRLESSYAYGGGNRTSDTAVTAPTGSSSYHGQRSDTHTVNESERGGNDSGKGTKQVDGEGGSLSLSEIGQGATFEQQQQRRRKRQ